Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-04-09 @ 5:52 PM
Study NCT ID:
NCT01707394
Status:
COMPLETED
Last Update Posted:
2021-03-22
First Post:
2012-10-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-12
First Submit QC Date:
None
Study First Post Date:
2012-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-19
Last Update Post Date:
2021-03-22
Last Update Post Date Type:
ACTUAL